Cybin Stock Price, News & Analysis
Company Description
Cybin (NASDAQ: HELP) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $255.5M, ranking #4,260 among all listed U.S. companies by market cap.
HELP stock has declined 33.8% over the past year. Shares last traded at $5.12.
This page provides a comprehensive overview of HELP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cybin (HELP) stock last traded at $5.12. Over the past 12 months, the stock has lost 33.8%. At a market capitalization of $255.5M, HELP is classified as a micro-cap stock with approximately 50.0M shares outstanding.
Latest News
Cybin has 7 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include management, clinical trial, earnings. View all HELP news →
SEC Filings
Cybin has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on March 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HELP SEC filings →
Financial Highlights
Upcoming Events
Phase 3 HLP003 topline
Topline Phase 3 data HLP003
Cybin has 2 upcoming scheduled events. The next event, "Phase 3 HLP003 topline", is scheduled for October 1, 2026 (in 180 days). Investors can track these dates to stay informed about potential catalysts that may affect the HELP stock price.
Short Interest History
Short interest in Cybin (HELP) currently stands at 3.5 million shares, up 6.5% from the previous reporting period, representing 8.3% of the float. Over the past 12 months, short interest has increased by 15.4%.
Days to Cover History
Days to cover for Cybin (HELP) currently stands at 2.0 days, down 59.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 62% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.0 to 9.8 days.
HELP Company Profile & Sector Positioning
Cybin (HELP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.